Media Room
Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.
For media inquiries, please contact us at [email protected].
-
Media Room Article
Cancer Research Institute Announces First Recipients of the New CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
New CRI health equity program supports young Black, Hispanic, and Latino scientists in the fields of immunology…
-
Media Room Article
Cancer Research Institute Awards $28.5 Million in Grants and Fellowships
The Cancer Research Institute awarded $28.5 million to scientists at 43 institutions in 8 countries who are…
-
Media Room Article
El Cancer Research Institute otorga 28.5 millones de dólares en subvenciones y becas
Durante su ciclo de financiamiento de 2021, el Cancer Research Institute otorgó 28.5 millones de dólares a…
-
Media Room Article
El Cancer Research Institute anuncia los primeros beneficiarios de la nueva Beca Irvington de posdoctorado para promover la diversidad racial
El nuevo programa de equidad en la salud del CRI apoya a jóvenes científicos afrodescendientes, hispanos y…
-
Media Room Article
Cancer Research Institute (CRI) Launches Spanish-Language Resource Hub in Its Commitment to Lead the Change in Racial Health Equity
This 9th annual Cancer Immunotherapy Month™, CRI aims to help close the information and research gap to…
-
Media Room Article
El Cancer Research Institute Lanza Su Website Como Centro De Información En Español, En Su Compromiso De Liderar El Cambio Por La Igualdad Racial En El Cuidado De La Salud
En conmemoración del 9o aniversario del Mes de la Inmunoterapia contra el Cáncer, el CRI tiene como…
-
Media Room Article
Cancer Research Institute Celebrates Ninth Annual Cancer Immunotherapy Month™
Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic…
-
Media Room Article
El Cancer Research Institute celebra el noveno Cancer Immunotherapy Month™ (Mes de la Inmunoterapia)
En junio, al celebrar el noveno Mes de la inmunoterapia, el Cancer Research Institute conmemora los avances…
-
Media Room Article
Cancer Research Institute and RevImmune Announce Dosing of First Patient in New Phase 2 Study Assessing Therapeutic Benefit of Interleukin-7 in Patients with Cancer and COVID-19
First study to test RevImmune’s IL-7 drug candidate in cancer patients infected with the SARS-CoV-2 coronavirus at…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.